Dier Mardi sold MDGL
March 6, 2026 · Form 4 insider transaction
Dier Mardi sold 40 shares of Madrigal Pharmaceuticals, Inc. at $425.08 per share, a transaction worth $17.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
40
Price
$425.08
Total value
$17.0K
InsiderDier Mardi
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 6, 2026
Filing dateMarch 6, 2026
Shares owned after13,786
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 2, 2025.